Kent J R, Almond M K
Department of Medicine, Southend Hospital, Essex, United Kingdom.
Perit Dial Int. 2000 May-Jun;20(3):301-5.
This survey examined the current management of continuous ambulatory peritoneal dialysis (CAPD) peritonitis and the effectiveness of the various antibiotic protocols in use.
The information required was elicited via a postal questionnaire.
The questionnaire was posted to each renal dialysis unit offering CAPD throughout the North and South Thames National Health Service regions.
All patients using CAPD at each responding unit were eligible for inclusion.
Each unit provided details of their CAPD peritonitis episodes for 1997. Each unit's empirical treatment regimen for CAPD peritonitis was sought in addition to response rates. Also requested were numbers for peritonitis episodes, recurrences, and negative cultures, plus the peritonitis rate per patient-month.
Thirteen units returned the questionnaire (87% of the survey population). Nine of the 13 units were using vancomycin regimens, with the remainder using cephalosporin regimens. The results were compared to the audit standards of the British Renal Association. Seventy percent of units reached the 80% mark for response rate; similar results were achieved with both the vancomycin and cephalosporin regimens. Ninety-two percent achieved the suggested peritonitis rate of 1 episode every 18 patient-months; 30% achieved the culture-negative rate of 10%. The average recurrence rate was 19%.
The units contacted achieved most of the standards suggested by the British Renal Association; however, wide variations did exist. Recent guidelines have suggested avoiding vancomycin-based regimens in order to reduce the incidence of vancomycin resistance. The suggested regimen of a cephalosporin with an aminoglycoside seems to represent a suitable alternative.
本调查研究了持续性非卧床腹膜透析(CAPD)腹膜炎的当前管理方法以及各种正在使用的抗生素方案的有效性。
所需信息通过邮寄问卷的方式获取。
问卷被寄给了泰晤士河南北两岸国民医疗服务体系区域内提供CAPD的每个肾脏透析单位。
每个回复单位中所有使用CAPD的患者均符合纳入条件。
每个单位提供了其1997年CAPD腹膜炎发作的详细情况。除了有效率外,还询问了每个单位针对CAPD腹膜炎的经验性治疗方案。还要求提供腹膜炎发作次数、复发次数、培养阴性次数,以及每患者月的腹膜炎发生率。
13个单位返回了问卷(占调查总体的87%)。13个单位中有9个使用万古霉素方案,其余单位使用头孢菌素方案。结果与英国肾脏协会的审核标准进行了比较。70%的单位达到了80%的有效率;万古霉素方案和头孢菌素方案都取得了类似的结果。92%的单位达到了每18患者月1次发作的建议腹膜炎发生率;30%的单位达到了10%的培养阴性率。平均复发率为19%。
被联系的单位达到了英国肾脏协会建议的大多数标准;然而,确实存在很大差异。最近的指南建议避免使用基于万古霉素的方案,以降低万古霉素耐药性的发生率。建议的头孢菌素与氨基糖苷类药物联合方案似乎是一个合适的替代方案。